1. Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
The no-question winner is Regeneron Pharmaceuticals with a gain of 800% since the market reached all-time highs back on October 7, 2007. The company has gone from a small speculative $2 billion company to a biotechnology powerhouse valued at almost $17 billion. The company has increased its revenue five-fold and is expecting a breakout year in 2013. Some have suggested that the stock is expensive, but because of its Orphan drug status, its valuation is consistent with others in the space. Personally, I think it could be another great year(s) for investors of Regeneron as it grows revenue, develops new products, and exhibits market leading performance. However, with a $16.7 billion market cap, I don’t think the company sees an 800% return over the next five years. Yet consistent gains of 20%-30% are not impossible.
When you look at these stocks, consider what made them move, and their overall performance, you can’t help but to be amazed. These are all companies that had to continuously prove doubters wrong and have excelled while the market traded flat. In my opinion, there is still some value to these five stocks, but investors should perform their own due diligence and make a decision as to whether one or more would benefit your portfolio.
The article A Look at the Best Performing Stocks Since the Market’s All-Time High originally appeared on Fool.com and is written by Brian Nichols.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.